| Literature DB >> 28645649 |
Renata Oliveira Soares1, Adriana Medianeira Rossato2, Gustavo Enck Sambrano2, Neidimar Cezar Corrêa Tolfo2, Juliana Caierão2, Thiago Galvão da Silva Paim2, Pedro Alves d'Azevedo2.
Abstract
Rapid identification of vancomycin-resistant enterococci (VRE) can assist in choosing the appropriate treatment and preventing VRE spread. The performance of chromID™ VRE agar was evaluated using 184 clinical isolates of Enterococcus spp. and reference strains. The test had a sensitivity of 95.52% but a low specificity of 30%.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28645649 PMCID: PMC5628312 DOI: 10.1016/j.bjm.2017.03.005
Source DB: PubMed Journal: Braz J Microbiol ISSN: 1517-8382 Impact factor: 2.476
Clinical isolates used to evaluated the performance of the chromID™ VRE.
| Species | Susceptibility to vancomycin | Origin | ||
|---|---|---|---|---|
| S | R | Infection | Surveillance culture | |
| 43 | 47 | 47 | 43 | |
| 7 | 87 | 75 | 19 | |
| Total | 50 | 134 | 122 | 62 |
S, susceptible; R, resistant.
Fig. 1Schematic representation of the results obtained using chromID™ VRE.
Evaluation of chromID™ VRE in detecting true positive vancomycin-resistant enterococci.
| ChromID™ VRE agar | Gold standard (VRE) | Gold standard (VSE) | Total |
|---|---|---|---|
| Test positive | 128 | 35 | 163 |
| Test negative | 6 | 15 | 21 |
| Total | 134 | 50 | 184 |
| Sensitivity | 95.52% (95% C.I. = 92.02–99.02%) | ||
| Specificity | 30.00% (95% C.I. = 17.29–42.70%) | ||
| Positive predictive value | 78.53% (95% C.I. = 72.22–84.83%) | ||
| Negative predictive value | 71.43% (95% C.I. = 52.10–90.75%) | ||
| Accuracy | 77.72% (95% C.I. = 71.70–83.73%) | ||
Vancomycin resistance was determined using both Etest® and CLSI guidelines; C.I., confidence intervals.